THY1 and systemic sclerosis: To confirm the functional effect of this finding in patient samples, we performed siRNA knockdown experiments in healthy and SSc fibroblasts and found that knockdown of Thy-1 in SSc specifically ameliorated aSMA expression suggesting that Thy-1 may play a pathogenic role.